Bone Marrow Transplant Associated Thrombotic Microangiopathy
Bone Marrow Transplant Associated Thrombotic Microangiopathy
复制标题
骨髓移植相关血栓性微血管病
DOI:
10.1080/10245332.2000.11746488
复制
发表时间:
2000
期刊:
影响因子:
1.9
通讯作者:
C. Uderzo
中科院分区:
文献类型:
--
作者:
A. Busca;C. Uderzo
Thrombotic microangiopathy is a severe microvascular disorder which may occur in up to 70% of patients undergoing bone marrow transplant. Clinically the term thrombotic microangiopathy encompasses a wide spectrum of syndromes, most importantly the thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). Thrombotic microangiopathy is characterized by the presence of thrombocytopenia, microangiopathic hemolytic anemia, renal impairment, neurological disturbances and multiorgan failure. Several causative agents have been advocated as triggering factors for bone marrow transplant associated thrombotic microangiopathy, including cyclosporine, FK506, the use of total body irradiation, infections and the presence of severe graft-versus-host disease. Plasma exchange represents the standard treatment for patients who develop TTP/HUS after bone marrow transplant, however, the mortality rate still remains high despite aggressive therapy.
登录
查看更多内容
影响因子:
4.8
作者:
Juckett,M;Perry,EH;Daniels,BS;Weisdorf,DJ
通讯作者:
Weisdorf,DJ
影响因子:
20.3
作者:
Burns,ER;Zucker-Franklin,D
通讯作者:
Zucker-Franklin,D
影响因子:
20.3
作者:
Mitra, D;Jaffe, EA;Laurence, J
通讯作者:
Laurence, J
影响因子:
4.8
作者:
Sviland,L;Sale,GE;Myerson,D
通讯作者:
Myerson,D
影响因子:
20.3
作者:
P. Richardson;A. Elias;A. Krishnan;C. Wheeler;R. Nath;D. Hoppensteadt;Nancy M. Kinchla;D. Neuberg;E. Waller;J. Antin;R. Soiffer;J. Vredenburgh;M. Lill;A. Woolfrey;S. Bearman;M. Iacobelli;J. Fareed;E. Guinan
通讯作者:
P. Richardson;A. Elias;A. Krishnan;C. Wheeler;R. Nath;D. Hoppensteadt;Nancy M. Kinchla;D. Neuberg;E. Waller;J. Antin;R. Soiffer;J. Vredenburgh;M. Lill;A. Woolfrey;S. Bearman;M. Iacobelli;J. Fareed;E. Guinan